These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3088594)

  • 21. Voluntary prospective payment plan creates cost-control incentive.
    Bradley AW; Regenstrief DI; Wallace WA
    Hosp Prog; 1983 Mar; 64(3):42-4, 71. PubMed ID: 10273332
    [No Abstract]   [Full Text] [Related]  

  • 22. Medicare home health reimbursement alternatives: access, quality, and cost incentives.
    Schlenker RE; Shaughnessy PW
    Home Health Care Serv Q; 1992; 13(1-2):91-115. PubMed ID: 10126434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective payment in medical rehabilitation].
    Lüngen M; Lauterbach KW
    Rehabilitation (Stuttg); 2003 Jun; 42(3):136-42. PubMed ID: 12813650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Medicare payment rules: danger or opportunity for nursing?
    Kurtzman ET; Buerhaus PI
    Am J Nurs; 2008 Jun; 108(6):30-5. PubMed ID: 18535440
    [No Abstract]   [Full Text] [Related]  

  • 25. Medicare program; changes to the hospital inpatient prospective payment system for acute care hospitals and fiscal year 2010 rates; and changes to the long-term care hospital prospective payment system and rate years 2010 and 2009 rates. Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2009 Aug; 74(165):43753-4236. PubMed ID: 19827228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicare payment system for hospital inpatients: diagnosis-related groups.
    Baker JJ
    J Health Care Finance; 2002; 28(3):1-13. PubMed ID: 12079147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute-care hospitals: a decade of surprises (1983 to 1993).
    Ginzberg E
    Bull N Y Acad Med; 1994; 71(1):58-68. PubMed ID: 8069277
    [No Abstract]   [Full Text] [Related]  

  • 28. Hospital cost control in Norway: a decade's experience with prospective payment.
    Crane TS
    Public Health Rep; 1985; 100(4):406-17. PubMed ID: 3927385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of prospective reimbursement on trauma patients.
    Jacobs LM
    Conn Med; 1985 Oct; 49(10):662-6. PubMed ID: 3933904
    [No Abstract]   [Full Text] [Related]  

  • 30. The state-of-the-science: challenges in designing postacute care payment policy.
    Chan L
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1522-5. PubMed ID: 17964899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prospective payment system of medical cost and surgical cancer treatment].
    Yamaguchi T
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1164-8. PubMed ID: 15332537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A community hospital payment experiment outperforms national experience. The Hospital Experimental Payment program in Rochester, NY.
    Block JA; Regenstreif DI; Griner PF
    JAMA; 1987 Jan; 257(2):193-7. PubMed ID: 3540325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An examination of winners and losers under Medicare's prospective payment system.
    Bray N; Carter C; Dobson A; Watt JM; Shortell S
    Health Care Manage Rev; 1994; 19(1):44-55. PubMed ID: 8206761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hospital cancer program: its value to the administrator.
    Russe HP
    Bull Am Coll Surg; 1980 Sep; 65(9):8-10. PubMed ID: 10309252
    [No Abstract]   [Full Text] [Related]  

  • 36. [The financing characteristics of psychiatric hospitals based on the principle of diagnosis-related (clinico-statistical) groups (a review)].
    Rytik EG; Shevchenko LS; Solokhina TA; Seĭku IuV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(11):107-11. PubMed ID: 1666207
    [No Abstract]   [Full Text] [Related]  

  • 37. Competition and prospective payment: a new way to control health costs.
    Averill RF; Kalison MJ
    J Am Health Policy; 1993; 3(2):22-8. PubMed ID: 10126974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital cost containment in Rochester: from Maxicap to the hospital experimental payments program.
    Sorensen AA; Saward EW; Stewart DW
    Inquiry; 1982; 19(4):327-35. PubMed ID: 6218086
    [No Abstract]   [Full Text] [Related]  

  • 39. Implementing Medicare prospective pricing by diagnosis related groups.
    Crawford M
    Ala J Med Sci; 1984 Jan; 21(1):96-100. PubMed ID: 6422785
    [No Abstract]   [Full Text] [Related]  

  • 40. Will DRG payments creep into all US health insurance plans?
    Korcok M
    Can Med Assoc J; 1984 Apr; 130(7):912-5. PubMed ID: 6423253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.